Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study

被引:4
|
作者
Goble, Spencer R. [1 ]
Ismail, Abdellatif S. [2 ]
Debes, Jose D. [3 ]
Leventhal, Thomas M. [4 ]
机构
[1] Hennepin Healthcare, Dept Med, 730 South 8th St, Minneapolis, MN 55415 USA
[2] Univ Maryland, Med Ctr, Dept Internal Med, Midtown Campus,827 Linden Ave, Baltimore, MD 21201 USA
[3] Univ Minnesota, Dept Med, Mayo Mem Bldg,MMC 250,420 Delaware St SE, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Div Gastroenterol Hepatol & Nutr, MMC 36,420 Delaware St SE, Minneapolis, MN 55455 USA
关键词
Palliative care; Intensive care units; Patient care planning; INTENSIVE-CARE; RENAL-FAILURE; ILL PATIENTS; MECHANICAL VENTILATION; MORTALITY; MANAGEMENT; COMPLICATIONS; PREDICTORS; INFECTION; THERAPY;
D O I
10.1186/s13054-024-04938-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Prior assessments of critical care outcomes in patients with cirrhosis have shown conflicting results. We aimed to provide nationwide generalizable results of critical care outcomes in patients with decompensated cirrhosis. Methods This is a retrospective study using the National Inpatient Sample from 2016 to 2019. Adults with cirrhosis who required respiratory intubation, central venous catheter placement or both (n = 12,945) with principal diagnoses including: esophageal variceal hemorrhage (EVH, 24%), hepatic encephalopathy (58%), hepatorenal syndrome (HRS, 14%) or spontaneous bacterial peritonitis (4%) were included. A comparison cohort of patients without cirrhosis requiring intubation or central line placement for any principal diagnosis was included. Results Those with cirrhosis were younger (mean 58 vs. 63 years, p < 0.001) and more likely to be male (62% vs. 54%, p < 0.001). In-hospital mortality was higher in the cirrhosis cohort (33.1% vs. 26.6%, p < 0.001) and ranged from 26.7% in EVH to 50.6% HRS. Mortality when renal replacement therapy was utilized (n = 1580, 12.2%) was 46.5% in the cirrhosis cohort, compared to 32.3% in other hospitalizations (p < 0.001), and was lowest in EVH (25.7%) and highest in HRS (51.5%). Mortality when cardiopulmonary resuscitation was used was increased in the cirrhosis cohort (88.0% vs. 72.1%, p < 0.001) and highest in HRS (95.7%). Conclusions One-third of patients with cirrhosis requiring critical care did not survive to discharge in this U.S. nationwide assessment. While outcomes were worse than in patients without cirrhosis, the results do suggest better outcomes compared to previous studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Paralytic ileus in the United States: A cross-sectional study from the national inpatient sample
    Solanki, Shantanu
    Chakinala, Raja Chandra
    Haq, Khwaja Fahad
    Singh, Jagmeet
    Khan, Muhammad Ali
    Solanki, Dhanshree
    Vyas, Manasee J.
    Kichloo, Asim
    Mansuri, Uvesh
    Shah, Harshil
    Patel, Achint
    Haq, Khwaja Saad
    Iqbal, Umair
    Nabors, Christopher
    Khan, Hafiz Muzaffar Akbar
    Aronow, Wilbert S.
    SAGE OPEN MEDICINE, 2020, 8
  • [2] Trends in inpatient burden from pressure injuries in the United States: Cross-sectional study National Inpatient Sample 2009-2019
    Choragudi, Siri
    Andrade, Luis F.
    Bermudez, Narges Maskan
    Burke, Olivia
    Sa, Brianna Christina
    Kirsner, Robert S.
    WOUND REPAIR AND REGENERATION, 2024, 32 (04) : 487 - 499
  • [3] Coexisting Cirrhosis Worsens Inpatient Outcomes in Patients With Infective Endocarditis: A Cross-Sectional Analysis of the National Inpatient Sample 2013-2014
    Jamil, Mohammad
    Kichloo, Asim
    Soni, Ronak G.
    Jamal, Shakeel
    Khan, Muhammad Zatmar
    Patel, Mitra
    Albosta, Michael S.
    Aljadah, Michael
    Bailey, Beth
    Singh, Jagmeet
    Kanjwal, Khalil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [4] Critical Care Boarding Practices of the Emergency Departments: A Cross-Sectional Study of a National Sample
    Goel, N. N.
    Lin, M.
    Vargas-Torres, C.
    Mathews, K. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Vascular Anomalies Care in the United States: A Cross-Sectional National Survey
    Cohen-Cutler, Sally
    Blatt, Julie
    Bayliff, Sherry
    Iacobas, Ionela
    Hammill, Adrienne
    Sisk, Bryan A.
    JOURNAL OF PEDIATRICS, 2023, 261
  • [6] HOW DOES THE "WEEKEND EFFECT" INFLUENCE OUTCOMES IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS? - NATIONAL INPATIENT SAMPLE STUDY
    Sanekommu, Harshavardhan
    Hapshy, Vera
    Boateng, William K.
    Schreiber, Christopher
    Bhatti, Talal K.
    Taj, Sobaan
    Hossain, Mohammad A.
    Rockey, Don C.
    GASTROENTEROLOGY, 2024, 166 (05) : S1590 - S1590
  • [7] Whipple's disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study
    Ahmad, Akram I.
    Wikholm, Colin
    Pothoulakis, Ioannis
    Caplan, Claire
    Lee, Arielle
    Buchanan, Faith
    Kyoo Cho, Won
    MEDICINE, 2022, 101 (49) : E32231
  • [8] SAFETY AND OUTCOMES OF PCI AND CABG IN PATIENTS WITH COMPENSATED AND DECOMPENSATED CIRRHOSIS: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE
    Fratti, Juan Del Cid
    Salazar, Miguel
    Palacios, Pedro
    Rios, Luis H. Paz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1517 - 1517
  • [9] Systemic Lupus Erythematosus and Angioedema: A Cross-Sectional Study From the National Inpatient Sample
    Luo, Yiming
    Fan, Xiaowen
    Jiang, Changchuan
    Ramos-Rodriguez, Alvaro
    Wen, Yumeng
    Zhang, Jianglin
    Huang, Feng
    Guan, Xizhou
    Xu, Jiehui
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (03) : 301 - 307
  • [10] Racial disparities in inpatient palliative care consultation among frail older patients undergoing high-risk elective surgical procedures in the United States: a cross-sectional study of the national inpatient sample
    Kim, Kyung Mi
    Muench, Ulrike
    Maki, John E.
    Yefimova, Maria
    Oh, Anna
    Jopling, Jeffrey K.
    Rinaldo, Francesca
    Shah, Nirav R.
    Giannitrapani, Karleen Frances
    Williams, Michelle Y.
    Lorenz, Karl A.
    HEALTH AFFAIRS SCHOLAR, 2023, 1 (02):